Mitsuharu Shiozaki

Title: Mitsuharu Shiozaki: Innovator in Antitumor Agent Production

Introduction

Mitsuharu Shiozaki is a notable inventor based in Yono, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral antitumor agents. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Shiozaki holds a patent for a novel process for producing 1-.beta.-D-arabinofuranosylcytosine-5'-stearylphosphate monosodium salt. This compound has been recognized for its potential as an oral antitumor agent. Additionally, he has developed 1-.beta.-D-arabinofranosylcytosine-5'-stearylphosphate monosodium salt monohydrate, which is derived from the aforementioned monosodium salt.

Career Highlights

Throughout his career, Mitsuharu Shiozaki has worked with prominent companies in the pharmaceutical industry. He has been associated with Yamasa Shoyu Co., Ltd. and Nippon Kayaku Co., Ltd. His experience in these organizations has contributed to his knowledge and expertise in the field of drug development.

Collaborations

Shiozaki has collaborated with esteemed colleagues, including Takashi Terada and Minoru Aoki. Their combined efforts have furthered research and innovation in the pharmaceutical sector.

Conclusion

Mitsuharu Shiozaki is a distinguished inventor whose work in producing antitumor agents has made a significant impact in the medical field. His contributions continue to inspire advancements in pharmaceutical research and development.